Evidence map›Paper›PMID 33468595›Full record

ReviewJournal of bacteriology2021

Seeing and Touching the Mycomembrane at the Nanoscale.

Albertus Viljoen, Esther Räth, John D Mckinney, Georg E Fantner, Yves F Dufrêne

Open access · greenAbstract readReview
In one paragraph

Review in Journal of bacteriology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Albertus Viljoen *Louvain Institute of Biomolecular Science and Technology, UCLouvain, Louvain-la-Neuve, Belgium.ORCID 0000-0001-8949-7401
Esther Räth *School of Engineering, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.
John D MckinneySchool of Life Sciences, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.ORCID 0000-0002-0557-3479
Georg E FantnerSchool of Engineering, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland georg.fantner@epfl.ch yves.dufrene@uclouvain.be.ORCID 0000-0001-5889-3022
Yves F DufrêneLouvain Institute of Biomolecular Science and Technology, UCLouvain, Louvain-la-Neuve, Belgium georg.fantner@epfl.ch yves.dufrene@uclouvain.be.ORCID 0000-0002-7289-4248
École Polytechnique Fédérale de Lausanne · CHUCLouvain · BEWalloon Excellence in Lifesciences and Biotechnology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycobacteria have unique cell envelopes, surface properties, and growth dynamics, which all play a part in the ability of these important pathogens to infect, evade host immunity, disseminate, and resist antibiotic challenges. Recent atomic force microscopy (AFM) studies have brought new insights into the nanometer-scale ultrastructural, adhesive, and mechanical properties of mycobacteria. The molecular forces with which mycobacterial adhesins bind to host factors, like heparin and fibronectin, and the hydrophobic properties of the mycomembrane have been unraveled by AFM force spectroscopy studies. Real-time correlative AFM and fluorescence imaging have delineated a complex interplay between surface ultrastructure, tensile stresses within the cell envelope, and cellular processes leading to division. The unique capabilities of AFM, which include subdiffraction-limit topographic imaging and piconewton force sensitivity, have great potential to resolve important questions that remain unanswered on the molecular interactions, surface properties, and growth dynamics of this important class of pathogens.

Indexed as

Adhesins, BacterialAnti-Bacterial AgentsCell MembraneHydrophobic and Hydrophilic InteractionsMembrane LipidsMicroscopy, Atomic ForceMycobacteriumSurface PropertiesAdhesins, BacterialAnti-Bacterial AgentsMembrane Lipidsadhesinsatomic force microscopybinding forcechemical propertiesdrugsgrowth dynamicsmycobacterial envelopeultrastructure

Identifiers

PMID33468595
PMCPMC8088606
OpenAlexW3122720499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.